Sign in
Taking peopleNo phase

Protocol for a Randomized Controlled Trial of a Clinician-Supervised Home-School-Hospital-Linked Digital Health Platform-Supported Conservative Management Pathway for AIS

Key facts

Who runs it
Hangzhou Medical College
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
76 people, planned
Started
26 Mar 2025
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Routine Guideline-Based Conservative Care
  • Clinician-Supervised, Platform-Assisted Conservative Management
Record updated
27 October 2026

Who can take part

Age
12 years to 16 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Confirmed diagnosis of mild-to-moderate Adolescent Idiopathic Scoliosis (AIS), with a Cobb angle of 10 degrees or greater and less than 45 degrees
  • Age 12 to 16 years, targeting adolescents in the active pubertal growth phase, in whom conservative management (PSSE and bracing) is clinically prioritized
  • Sufficient cognitive and communicative ability to understand the study procedures and use the platform
  • Voluntary participation confirmed by signed guardian informed consent and adolescent participant assent
  • Participants with prior conservative treatment (PSSE or bracing) are eligible provided the treatment regimen has been stable for at least 3 months prior to baseline assessment

Who cannot take part

  • Secondary scoliosis caused by identifiable causes such as spinal trauma or prior spinal surgery
  • Clinically significant severe functional impairment of heart, liver, or kidney organ function, defined as grade 3 or higher organ dysfunction according to CTCAE version 5.0
  • Malignant tumours, autoimmune diseases, or other critical systemic illnesses that may interfere with trial outcomes
  • Severe cognitive or psychiatric conditions, including diagnosed intellectual disability, psychotic disorders, or major depressive disorder under active psychiatric intervention, that prevent obtaining valid assent or completing study assessments

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 12 and 16 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Adolescent idiopathic scoliosis (AIS) brings substantial physical and psychological burden to affected teenagers, and current conservative follow-up management is fragmented under routine clinical settings. This single-center, superiority, parallel-group, 1:1 randomized controlled trial with assessor-blinded outcome evaluation will compare a clinician-supervised, platform-supported collaborative care pathway with routine guideline-based conservative care in 76 adolescents with mild-to-moderate AIS. Participants will be assessed at baseline, 4-month (primary endpoint), 8-month, and 12-month follow-up. The primary outcome is the change in Cobb angle from baseline to 4 months. Secondary outcomes include treatment adherence, mental-health status, medical expenditure, participant and guardian satisfaction, and safety outcomes. The primary analysis will follow the intention-to-treat principle. The first participant was enrolled on 26 March 2025; to date, 35 of the target 76 participants have been recruited.

The 2 groups in the trial

  • Routine Guideline-Based Conservative CareExisting treatment, for comparison

    Control participants will receive routine clinician-directed conservative management in accordance with the 2016 SOSORT guidelines, including observation (follow-up every 3-8 months), physiotherapeutic scoliosis-specific exercises (PSSE, 2-7 sessions per week), specialized inpatient rehabilitation (SIR, a 4-week intensive program of 1 h/day, 5 days/week), and bracing (nighttime rigid bracing 8 h/day; part-time rigid bracing 15 h/day; full-time rigid bracing 20 h/day) as clinically indicated. Care is delivered through routine outpatient visits, paper-based education materials, and clinic-driven follow-up reminders via telephone or SMS. Participants in this arm have no access to the digital health management platform.

  • Platform-Supported Individualized Conservative CareTreatment being tested

    Intervention participants will receive individualized conservative management supported by the comprehensive digital health management platform and supervised by licensed clinicians. The same guideline-based treatment options as the control group are available (observation, PSSE, specialized inpatient rehabilitation, and bracing), with treatment selection rules strictly following the 2016 SOSORT guidelines. The platform generates decision-support recommendations based on clinical characteristics, radiographic findings, and lifestyle-related risk factors; all platform-generated suggestions must be manually reviewed, adjusted, and formally approved by a licensed clinician before implementation. The platform provides treatment reminders, standardized health education, follow-up scheduling, and secure cross-party communication linking participants, families, schools, and healthcare providers (home-school-hospital collaborative care model).

    Treatment: Clinician-Supervised, Platform-Assisted Conservative Management

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Protocol for a Randomized Controlled Trial of a Clinician-Supervised Home-School-Hospital-Linked Digital Health Platform-Supported Conservative Management Pathway for Adolescent Idiopathic Scoliosis
Criteria questions
Built from NCT06314594, who can take part
Record updated
27 October 2026